The White House is working on an executive order that could come as soon as next week that will direct the firing of thousands of U.S. Department of Health and Human Services workers, people familiar with the matter told The Wall Street Journal’s Liz Essley Whyte and Betsy McKay. Under the order, the Food and Drug Administration, Centers for Disease Control and Prevention and other health agencies would have to cut a certain percentage of employees, the Journal noted. Publicly traded pharmaceutical companies include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded hospital companies include Community Health (CYH), HCA Healthcare (HCA), Tenet Healthcare (THC) and Universal Health (UHS). Publicly traded healthcare insurance companies include CVS Health (CVS), Centene (CNC), Cigna (CI), Elevance Health (ELV), Humana (HUM), Molina Healthcare (MOH) and UnitedHealth (UNH).
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Kura Oncology price target raised to $36 from $34 at Wedbush
- Senate panel advances Kennedy’s nomination for HHS secretary, CNBC reports
- Halozyme announces positive opinion in EU for rybrevant with Enhanze technology
- Johnson & Johnson price target raised to $166 from $162 at Guggenheim
- Opening Day: Infinity Natural Resources valued at $1.3B in market debut